StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 1,281.00
-24.00 (-1.84%)
May 12, 2025, 3:30 PM JST
StemCell Institute Revenue
StemCell Institute had revenue of 667.00M JPY in the quarter ending December 31, 2024, a decrease of -0.60%. This brings the company's revenue in the last twelve months to 2.64B, up 10.06% year-over-year. In the fiscal year ending March 31, 2024, StemCell Institute had annual revenue of 2.48B with 18.65% growth.
Revenue (ttm)
2.64B
Revenue Growth
+10.06%
P/S Ratio
5.07
Revenue / Employee
26.91M
Employees
98
Market Cap
13.37B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |